Consainsights logo

Infection Surveillance Solutions Market Size, Share, Industry Trends and Forecast to 2030

Infection Surveillance Solutions Market Research Report – Segmented By Region (North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America) – Analysis on Size, Share, Trends, COVID-19 Impact, Competitive Analysis, Growth Opportunities and Key Insights from 2019 to 2030.


  • Published date -30th Jan 2024

  • Formats -PDF, CSV

  • Region -Global

1. Market Size & CAGR of Infection Surveillance Solutions Market in 2021

The global infection surveillance solutions market is expected to reach a market size of USD 3.56 billion by the end of 2021. The compound annual growth rate (CAGR) for the market in 2021 is projected to be around 7.2%. This growth is driven by factors such as the increasing incidence of healthcare-associated infections (HAIs) and the rising adoption of infection surveillance solutions by healthcare facilities worldwide.

2. COVID-19 Impact on the Infection Surveillance Solutions Market

The ongoing COVID-19 pandemic has had a significant impact on the infection surveillance solutions market. With healthcare facilities overwhelmed and focusing on managing COVID-19 cases, the need for effective infection surveillance and control measures has never been more critical. As a result, there has been a surge in the adoption of infection surveillance solutions to monitor and prevent the spread of both COVID-19 and other healthcare-associated infections.

3. Infection Surveillance Solutions Dynamics

Infection surveillance solutions play a vital role in healthcare settings by enabling real-time monitoring, analysis, and reporting of infectious diseases. These solutions help healthcare facilities track and manage infections, identify trends, and implement targeted interventions to prevent outbreaks. The dynamics of the infection surveillance solutions market are driven by the increasing focus on patient safety, stringent regulations pertaining to infection control, and the growing demand for automation and digitization in healthcare.

4. Segments and Related Analysis

The infection surveillance solutions market can be segmented based on the type of solution, deployment mode, end-user, and region. Key segments include software solutions, hardware solutions, cloud-based solutions, on-premise solutions, hospitals, long-term care facilities, and more. The market analysis of each segment provides insights into the specific needs and trends driving the adoption of infection surveillance solutions.

5. By Region Analysis

The global infection surveillance solutions market can be analyzed based on regions such as North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Each region has unique healthcare challenges, regulations, and infrastructure that influence the adoption and growth of infection surveillance solutions. Understanding the regional dynamics is crucial for market players to tailor their strategies and offerings effectively.

6. Key Market Players and Competitive Landscape

Key players in the infection surveillance solutions market include companies like BD (Becton, Dickinson and Company), VigiLanz Corporation, RL Solutions, GOJO Industries, Wolters Kluwer, and more. These players are actively involved in product innovation, partnerships, and acquisitions to strengthen their market presence and offer advanced solutions to healthcare providers. The competitive landscape of the market is intense, with players vying for market share through differentiation and value-added services.

7. Recent Happenings in the Infection Surveillance Solutions Market

In recent years, the infection surveillance solutions market has witnessed significant developments and innovations. Companies have introduced AI-powered solutions, cloud-based platforms, and predictive analytics tools to enhance infection control and prevention efforts. The integration of wearable technology, real-time data monitoring, and interoperability with electronic health records have also been key trends shaping the market. These advancements are aimed at improving patient outcomes, reducing healthcare costs, and enhancing overall healthcare quality.

Infection Surveillance Solutions Market FAQs